SYS-CON MEDIA Authors: RealWire News Distribution, Kevin Benedict, Jason Bloomberg, Bob Gourley, Greg Schulz

News Feed Item

PURE Bioscience Initiates SDC Antimicrobial Testing With Three Additional National QSR Chains

SDC Antimicrobial Technology Provides Leading Edge for Food Safety

SAN DIEGO, CA -- (Marketwired) -- 05/19/14 -- PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that it has initiated testing of PURE® Hard Surface disinfectant and sanitizer in three additional national Quick Service Restaurant (QSR) chains. Also, the Company announced that it had smoothly completed the regional supply chain and distribution rollout to 650 units of a leading QSR chain, resulting in positive initial customer feedback on PURE Hard Surface.

GROWING INTEREST IN EVALUATING ADOPTION
The Company is actively developing growing interest of a number of QSR chains to perform in-store comparative efficacy tests, stimulated by the consistently compelling results achieved in the testing by PURE's initial market-leading QSR customer and the growing market awareness of SDC as a superior antimicrobial disinfectant for food contact surfaces. The three new QSR chains that PURE is working with cover a range of store "footprints" (from average to very large), and therefore, the anticipated product usage will vary accordingly.

  • In-store areas being tested include critical food contact surfaces such as food preparation counters, slicers and customer service counters, in addition to dining tables, beverage machines and ice dispensers.
  • In addition to quantitative efficacy testing, the QSRs will also record feedback from employees using PURE Hard Surface. In previous testing, employees have consistently preferred PURE over incumbent products due to the fact that it is easy to use, non-caustic and odorless with no skin or eye irritation.

"We are working with a growing group of forward thinking QSR chains and are confident that the in-store testing will continue to validate SDC as a superior antimicrobial disinfectant and sanitizer. This will prove to be a major step in dramatically reducing food safety risk," said Cliff Wechsler, PURE's Executive Vice President of Sales.

EXPANDED REGIONAL ROLLOUT COMPLETED FOR LEADING QSR CHAIN
Over the past 30 days, the Company successfully completed the previously announced expansion of PURE Hard Surface usage to 650 units of a leading QSR chain in three regional markets. The operational test is expected to run another 30-45 days. The initial feedback from the chain, and the stores using the PURE product, has been very encouraging. Subject to continued positive customer feedback, PURE expects the chain will move forward with a national, system-wide rollout this summer.

"We are encouraged to see a growing number of QSR chains of all sizes willing to test, evaluate and adopt our technology as a way to enhance their food safety practices," said Hank R. Lambert, PURE's Chief Executive Officer.

THE BENEFITS OF SDC
PURE Hard Surface delivers powerful broad-spectrum antimicrobial effectiveness while maintaining low toxicity (Category IV as defined by the US EPA), and its active ingredient, SDC, has been determined Generally Recognized as Safe (GRAS) for use as a biocide on food processing utensils, equipment and machinery. Created specifically for use on areas such as produce slicing equipment, food preparation counters, customer transaction counters, dining tables, soda machines and ice dispensers, PURE Hard Surface achieves a 96% improved efficacy performance compared with typically used disinfectants/sanitizers.

About PURE Bioscience, Inc.
PURE Bioscience, Inc. is focused on developing and commercializing its proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control within the food industry. The Company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. SDC is a broad-spectrum, non-toxic antimicrobial agent, which offers 24-hour residual protection. As a platform technology, SDC is distinguished from existing products in the marketplace by its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in El Cajon, California (San Diego metropolitan area). Additional information on PURE is available at www.purebio.com.

Forward-looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause our actual results to differ materially from the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the Company's cash position and liquidity requirements, the Company's failure to implement or otherwise achieve the benefits of its proposed business initiatives and plans, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, including to manufacture its products, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission, including our annual report on Form 10-K filed October 24, 2013. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

IR Contacts:
Tom Hemingway
Redwood Investment Group
Email Contact
714-978-4425

Terri MacInnis
VP of IR
Bibicoff + MacInnis, Inc.
Email Contact
818-379-8500

Company Contact:
Peter C. Wulff
CFO & COO
PURE Bioscience, Inc.
Email Contact
619-596-8600 ext.111

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.